Health Tech Capitol | Uncategorized
1
archive,paged,category,category-uncategorized,category-1,paged-36,category-paged-36,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Uncategorized

Madison Vaccines Incorporated’s clinical trial for metastatic prostate cancer is expanding to the University of Washington, its third site, the company announced recently. According to a release, MVI-118 is being explored for use in combination with androgen deprivation therapy to delay resistance and prolong duration of disease control...

MADISON, Wis., March 21, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the "company"), an oncology-focused, clinical stage biotechnology company, today announces the United States Patent and Trademark Office has granted a method of use patent for CLR 124, the company's cancer imaging agent, which...

Functional Biosciences, a Madison-based biotechnology company, has been awarded its CLIA Certification of Compliance from the Wisconsin Department of Health. Achieving CLIA compliance was no easy task, according to Kym Larson, laboratory director for Functional Biosciences. “It’s actually a very long process,” she said. “There’s a long...

In Madison, Wisconsin, technology entrepreneurs aren't just leading the field of healthcare; they're changing it. From Epic Systems' breakthrough software that revolutionized medical records, to Stratatech's regenerative skin therapies, the capital region of Wisconsin has been churning out innovative firms whose primary purpose is the promotion...